Although CNV-derived gene dysregulation is common in human cancers [14, 15], CNVs are not the main reason for the upregulation of GSG2 in breast cancers based on our analysis, suggesting that there are important transcription factors and epigenetic factors responsible for upregulating GSG2. The gene discussed is HASPIN; the disease is breast carcinoma.